Eli Lilly releases promising early-stage data on ADC for ovarian cancer
Summary
Seeking Alpha reports that Eli Lilly has released promising early-stage data on an antibody-drug conjugate (ADC) for ovarian cancer. Only the headline was available for this article, so no further details are included. A separate Seeking Alpha article about early-stage ADC results from Zymeworks in ovarian cancer was excluded because it covers a different company and data set.
Timeline
Seeking Alpha
Source ↗Reports that Eli Lilly released promising early-stage data on an ADC for ovarian cancer.
Comments
No comments yet.
to like and comment.